Imunon, Inc. (IMNN)
1.604
-0.04
(-2.20%)
USD |
NASDAQ |
Aug 24, 16:00
1.604
0.00 (0.00%)
After-Hours: 20:00
Imunon Shareholders Equity (Quarterly) : 4.189M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.189M |
| March 31, 2026 | 3.360M |
| December 31, 2025 | 7.062M |
| September 30, 2025 | 4.082M |
| June 30, 2025 | 2.660M |
| March 31, 2025 | 0.452M |
| December 31, 2024 | 4.244M |
| September 30, 2024 | 8.192M |
| June 30, 2024 | 3.741M |
| March 31, 2024 | 8.500M |
| December 31, 2023 | 13.39M |
| September 30, 2023 | 18.07M |
| June 30, 2023 | 21.52M |
| March 31, 2023 | 26.65M |
| December 31, 2022 | 29.33M |
| September 30, 2022 | 41.35M |
| June 30, 2022 | 47.04M |
| March 31, 2022 | 46.27M |
| December 31, 2021 | 55.80M |
| September 30, 2021 | 59.34M |
| June 30, 2021 | 64.05M |
| March 31, 2021 | 54.96M |
| December 31, 2020 | 18.61M |
| September 30, 2020 | 18.66M |
| June 30, 2020 | 24.21M |
| Date | Value |
|---|---|
| March 31, 2020 | 16.21M |
| December 31, 2019 | 14.56M |
| September 30, 2019 | 15.46M |
| June 30, 2019 | 18.83M |
| March 31, 2019 | 21.40M |
| December 31, 2018 | 20.86M |
| September 30, 2018 | 15.13M |
| June 30, 2018 | 19.15M |
| March 31, 2018 | 23.61M |
| December 31, 2017 | 26.70M |
| September 30, 2017 | 5.287M |
| June 30, 2017 | 6.649M |
| March 31, 2017 | 6.106M |
| December 31, 2016 | 6.726M |
| September 30, 2016 | 10.57M |
| June 30, 2016 | 16.51M |
| March 31, 2016 | 15.31M |
| December 31, 2015 | 20.39M |
| September 30, 2015 | 25.08M |
| June 30, 2015 | 29.11M |
| March 31, 2015 | 26.70M |
| December 31, 2014 | 32.83M |
| September 30, 2014 | 38.92M |
| June 30, 2014 | 45.36M |
| March 31, 2014 | 40.56M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Phio Pharmaceuticals Corp. | 12.60M |
| Agenus, Inc. | -199.08M |
| Amgen, Inc. | 11.69B |
| Anika Therapeutics, Inc. | 137.28M |
| BioCryst Pharmaceuticals, Inc. | -454.29M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.99M |
| Total Liabilities (Quarterly) | 10.80M |
| Debt to Equity Ratio | 1.873 |
| Current Ratio | 1.819 |
| Net Debt Paydown Yield | -16.47% |